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Our authors have provided us a healthy debate regarding the
appropriateness of endovascular repair (EVAR) of abdominal
aortic aneurysms in healthy, young patients. Common themes
were discussed with differing viewpoints regarding procedure
durability, life expectancy, and reintervention rates, challenging
us to put this into perspective and apply this information to our
own practices.
First, no one’s life expectancy is indeﬁnite and this includes the
supposedly “young, good-risk” aneurysm patient. Although these
patients should expect to live longer than their older counterparts,
the presence of an aneurysm reﬂects generalized cardiovascular risk
and they may not have the same life expectancy as nonaneurysm
patients. Regardless, these young, good-risk aneurysm patients
should expect at least a decade or two of longevity which provides
us with a horizon regarding long-term outcomes following aneu-
rysm repair.
There are well-known early advantages with EVAR in aneu-
rysm patients, regardless of patient age. Several randomized
controlled trials have consistently shown an early survival advan-
tage with EVAR in the ﬁrst 30 days. Admittedly, early postopera-
tive mortality should be low in young, good-risk patients,
regardless of method of repair, and this survival advantage could
be lost as mortality falls with open repair. The potential absence
of early survival advantage can be spun in different ways depending
on which side of the debate one sits. It can be seen as a “failure to
improve perioperative survival” by those who advocate open
repair, or as “equivalent to the gold standard” by endovascular
advocates. Of course, shorter hospital stay and quicker return to
work and normal activities provides further ammunition, in the
short term, for endovascular enthusiasts. The loss of this early
survival advantage with EVAR and the equivalence of longer-
term survival have been well described and discussed with respect
to these same randomized trials. It’s interesting that a negative
connotation is often applied to these ﬁndings, namely that
EVAR “fails to improve longer-term survival,” or there is “no
survival beneﬁt with EVAR,” rather than EVAR provides “similar
or equivalent long-term survival” compared to open repair.
The main crux of the argument is the durability of EVAR
compared to open repair in those with a longer life expectancy.
As highlighted by our authors, issues regarding durability include
anatomy, life expectancy, reinteventions, surveillance and
surgeon/hospital experience. Anatomy is by far the most impor-
tant factor in determining procedure durability when it comes to
aneurysm repair, regardless of if it’s EVAR or open. Manyattachment site EVAR reinterventions can be prevented by
ensuring adequate seal zones at the initial operation as reﬂected
by long, narrow, straight, and noncalciﬁed, nonthrombus-lined
infrarenal necks and long, nonaneurysmal common iliac arteries.
Similarly, appropriate selection of anastomotic sites during open
repair is essential to prevent aneurysmal progression in the adjacent
infrarenal aorta or common iliac arteries. Regardless, aorta speciﬁc
reinterventions will continue to be more common following
EVAR compared to open repair, with most being amenable to
further endovascular or percutaneous interventions. Often under-
appreciated, though, is that “access site,” or laparotomy-related,
reinterventions (incisional hernias, small bowel obstructions) or
more common after open repair and should be included in any
discussion regarding durability of aneurysm repair.
Surveillance regimens following both methods of repair are
important and worthy of discussion. Although most commonly
discussed with respect to EVAR, concerns regarding radiation
and cancer-causing effects of computed tomography (CT) scans
also apply to open repair. Surveillance following open repair is
important as well, and many advocate a CT scan or ultrasound
every 5 years following open repair. Surveillance regimens are
becoming less contingent on CT scans and as this continues,
surveillance itself shouldn’t be a factor in choosing method of
repair unless the surveillance regimen is important from the
patient’s perspective.
Health care costs and surgeon expertise and experience are
other issues raised by our authors and are factors that differ between
countries. Costs of EVAR and open repair have been widely
analyzed, but any analysis depends on its perspective, the jurisdiction
inwhich it takes place, its scope and time frame. Regarding expertise,
Drs Vallabhaneni and Farber raise an interesting point regarding
low-volume surgeons and hospitals in the U.S. being more adept
at EVAR than open repair. This is an important jurisdiction-speciﬁc
observation that reﬂects practice driving training driving practice
and could be the subject of a whole other debate.
Finally, should we consider EVAR in a young, good-risk
patient? Well, the durability of the procedure is relative to the
life expectancy of the patient and is predicted by anatomy. The
longer the life expectancy of the patient, the more perfect the
anatomy is required to maximize EVAR durability. So, the answer
is yes if the patient has excellent anatomy for EVAR. However, if
there is any anatomical feature that might hint at limited durability,
namely infrarenal neck and common iliac artery features, then an
open repair should be chosen.
